Cost-Benefit Analysis of Risperidone and Clozapine in the Treatment of Schizophrenia in Israel
Year of publication: |
1998
|
---|---|
Authors: | Ginsberg, Gary ; Shani, Segev ; Lev, Boaz |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 13.1998, 2, p. 231-241
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Pharmacoeconomics | Schizophrenia | Clozapine | Risperidone | Cost-benefit | Antipsychotics |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Shermock, Kenneth M., (2001)
-
Economic Considerations and Formulary Management of Oral Antipsychotics
Jann, Michael W., (1998)
-
Risperidone: A Pharmacoeconomic Review of its Use in Schizophrenia
Foster, Rachel H., (1998)
- More ...
-
Shani, Segev, (2000)
-
Prior hospitalization and age as predictors of mental health resource utilization in Israel
Ginsberg, Gary, (1997)
-
Cost Effectiveness of Treatments for Amyotrophic Lateral Sclerosis: A Review of the Literature
Ginsberg, Gary, (2002)
- More ...